Related references
Note: Only part of the references are listed.Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome
Chor-Cheung Frankie Tam et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Ticagrelor and Endothelial Function: An Effect That Persists Far From the Acute Phase and in Monotherapy
Rita Pavasini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial
Marc Laine et al.
AMERICAN HEART JOURNAL (2020)
P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes: Review of the Current Evidence
Laurent Bonello et al.
CIRCULATION (2018)
Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease
Heyang Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
Riyaad Aungraheeta et al.
BLOOD (2016)
Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
Duncan Armstrong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus
Antonio Tello-Montoliu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
Renli Teng et al.
PLATELETS (2013)
Antithrombotic Therapy in Patients With Chronic Kidney Disease
Davide Capodanno et al.
CIRCULATION (2012)
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment-Elevation Myocardial Infarction
Dimitrios Alexopoulos et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Current Understanding of Drug Disposition in Kidney Disease
Judith Naud et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Severe Renal Impairment
Kathleen Butler et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Ticagrelor in the Renal Dysfunction Subgroup: Subjugated or Substantiated?
Gilles Montalescot et al.
CIRCULATION (2010)
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Stefan James et al.
CIRCULATION (2010)
Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry
Henrik Sillen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Ticagrelor: The First Reversibly Binding Oral P2Y(12) Receptor Antagonist
Steen Husted et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Altered nonrenal drug clearance in ESRD
Thomas D. Nolin
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment
Dirk Sibbing et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Down-regulation of intestinal drug transporters in chronic renal failure in rats
Judith Naud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Design and analysis of pilot studies: recommendations for good practice
GA Lancaster et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2004)
Downregulation of intestinal cytochrome P450 in chronic renal failure
FA Leblond et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction
H Okabe et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
